Platinum complexes of substituted ethylenediamines and their anti-tumour activity. 1976

K P Beaumont, and C A McAuliffe, and M J Cleare

A large number of substituted ethylenediamine complexes of platinum (II) and platinum(IV) have been prepared and characterised, and their anti-tumour activity tested against sarcoma 180, leukemia L1210, and ADJ/PC6A plasma cell tumours. In general these complexes are less active than simpler amine analogues, though several complexes show activity against all of the screens. Difference in activity of platinum(II) and platinum(IV) analogues leads us to cast doubt on the "in vivo reduction" theory hitherto used to describe the action of platinum(IV) complexes.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010984 Platinum A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae". Platinum Black
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005029 Ethylenediamines Derivatives of ethylenediamine (the structural formula NH2CH2CH2NH2).
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

K P Beaumont, and C A McAuliffe, and M J Cleare
November 1972, Chemico-biological interactions,
K P Beaumont, and C A McAuliffe, and M J Cleare
September 1975, Chemico-biological interactions,
K P Beaumont, and C A McAuliffe, and M J Cleare
January 1978, Materia medica Polona. Polish journal of medicine and pharmacy,
K P Beaumont, and C A McAuliffe, and M J Cleare
January 1980, Toxicology,
K P Beaumont, and C A McAuliffe, and M J Cleare
April 1986, Anti-cancer drug design,
K P Beaumont, and C A McAuliffe, and M J Cleare
January 1960, Archives internationales de pharmacodynamie et de therapie,
K P Beaumont, and C A McAuliffe, and M J Cleare
January 2012, Dalton transactions (Cambridge, England : 2003),
K P Beaumont, and C A McAuliffe, and M J Cleare
November 1979, Chemical & pharmaceutical bulletin,
K P Beaumont, and C A McAuliffe, and M J Cleare
March 1956, British journal of pharmacology and chemotherapy,
Copied contents to your clipboard!